Detalhe da pesquisa
1.
Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV.
BMC Infect Dis
; 21(1): 910, 2021 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34488664